Allarity Therapeutics, Inc.
+14.2% · 90d
$1.37
+0.03 (+2.24%)
After-Hours $1.38(+0.01)
News
(1)April 2026
ALLR Shareholders to Vote on $6M Equity Line Proposal
ALLRAllarity Therapeutics, Inc.
# 🧾 What This Document Is — And Why You're Reading It This is a **PRELIMINARY PROXY STATEMENT (PRE 14A)** for Allarity Therapeutics, Inc. (ALLR). Think of it as an "information packet" the company sends to shareholders *before* their big annual meeting. Its job is to explain everything shareholder
Read summaryView on SEC EDGAR
Peers in Biotechnology
VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%